16.02.2020 20:00:00

Better Buy: AbbVie vs. Gilead Sciences

AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD) must have missed the invitation to the party the stock market threw last year. Both stocks trailed the S&P 500 index's performance in 2019 by a wide margin.However, both AbbVie and Gilead have been big winners in the past. And they both could deliver strong returns in the future. Which of these two stocks is the better pick right now? Here's how AbbVie and Gilead compare.Image source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Gilead Sciences Inc.mehr Analysen

15.03.19 Gilead Sciences Outperform BMO Capital Markets
03.01.19 Gilead Sciences Outperform Oppenheimer & Co. Inc.
26.10.18 Gilead Sciences overweight Barclays Capital
01.10.18 Gilead Sciences Overweight Cantor Fitzgerald
26.07.18 Gilead Sciences Neutral Robert W. Baird & Co. Incorporated

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!

Aktien in diesem Artikel

pagehit